Pure Global AI
ANVISA RDC

RDC 751/2022

Medical Device Registration and Classification
BrazilANVISAClassificationEffective March 1, 2023
Official source linked
What this code is

RDC 751/2022 is ANVISA Collegiate Board Resolution 751/2022. A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022).

Instrument
RDC
Full name
Resolução da Diretoria Colegiada
Category
Classification
Source links
Authority source
English
Open the issuing-authority text
ANVISA-hosted English text; confirm legal effect against the current official Portuguese publication.
Readable HTML
67 articles · 2 language versions
Read the full text →
Direct citations can link to an article, for example /data/regulations/brazil/rdc-751-2022.en.html#art-1.
Dates
Published
September 21, 2022
Effective
March 1, 2023
Readable full text

Open a language version

Each version has stable article anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

English full text67 articles · English — ANVISA translationRead HTML →Portuguese full text67 articles · Portuguese — official textRead HTML →
About this regulation

Medical Device Registration and Classification

Core regulation for medical device classification (Class I-IV) and registration pathways (notification vs. marketing authorization) in Brazil.

A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022). Always confirm the current consolidated text and transition provisions with the official source before filing.

Verified